FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> modeling | animal testing

Better modeling to reduce animal testing

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

Drug testing via computer modeling, virtual tissue, and human and animal cells are helping the pharma industry move away from the use of animals as primary test subjects.

Researchers recruit tens of millions of animals annually for drug testing, reports The Baltimore Sun. Eighty to 800 are needed per drug.

Robert Kavlock, director at the EPA's National Center for Computational Toxicology, says animals represent the current "gold standard" in drug testing, according to the article. "But there is a collective recognition that we need to do better." And there are solid practical reasons to move away from the use of animals. A chemical that costs $6 million to $10 million to test might yield computer test results for "more like $20,000."

- here's the article

Related Article:
FDA, Tox21 try IT in place of animal tests


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about modeling   animal testing